ClinicalTrials.gg
Active, not recruitingNCT06552312Updated May 18, 2025

A Modified Delphi for ECPR Post Resuscitation Care

An observational study in Cardiac Arrest, sponsored by Sydney Local Health District. Active, not recruiting at 1 site in Australia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-18.

Sponsored by Sydney Local Health District · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as active, not recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Heart Arrest with a site in Australia — 3 open to participants now, 5 under way, 1 of them phase 3. Heart Arrest · Australia.

Started
2024
the only one that year
Observational
5 of 14
2 open now
Registered
13th of 14
by date
Lead sponsor
1 of 14
Sydney Local Health District

Among the 14 studies in Heart Arrest with a site in Australia, this one is the only one that started in 2024, is one of 5 observational ones, and was the 13th registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

3 of the 14 studies in Heart Arrest with a site in Australia are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Australia have not opened yet or have stopped. Only those recruiting at a site in Australia →

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Heart Arrest with a site in Australia, or all of them as a file.
02

Study summary

The objective of this study is to generate expert consensus statements on the management of out of hospital cardiac arrest (OHCA) patients treated with extracorporeal membrane oxygenation (ECMO) cardiopulmonary resuscitation (ECPR).

Read the detailed description

The study will be performed using a modified Delphi process with an international expert panel to generate recommendation statements related to the management of patients treated with ECPR and to determine the level of agreement for each statement from the panel as a whole. The following topics will be covered:

Sedation Mechanical ventilation management Oxygen management Carbon dioxide management Haemodynamic management ECMO flow management Mean arterial pressure targets Aortic valve not opening management Left ventricular unloading/venting Complication management Infection prevention Anticoagulation Imaging Prognostication and neuro-prognostication Practical recommendations Organ donation Patient followup

Cannulation will not be covered as this has been covered in other Delphi processes.

Management Consensus is achieved through iterative rounds of survey and revision to the statements until a pre-determined level of agreement is met (>70% agreement).

Part 1: planning and evidence review Series of planning sessions with co-chairs Literature is reviewed/summarized Initial statements will be developed based on evidence and study team expertise

Expert panel selection:

The study team identified experts on ECPR for OHCA based on contributions to the field, clinical experiences, range of specialties and peer-reviewed publications with prioritization of diversity in geography and expertise. Using snowball sampling, investigators will ask the recruited experts to identify additional content experts to participate in the expert panel. It is aimed to recruit a total of 50 experts, in accordance with the recommended panel number of >30 as outlined in the original Delphi method paper. To avoid any bias, the study team will not participate in the voting process. The survey and voting process will be online and anonymous to avoid any reciprocal influence.

Part 2: Survey to achieve consensus Survey, based on the initial statements developed by study team, will be developed. This will be reviewed by independent contributors (not part of the study team or the expert panel), to ensure validity, appropriate topic coverage and length.

Some questions will enable a Yes/No or quantitative response. Others will be utilising a Likert scale. The voting process will be anonymous to avoid any reciprocal influence or dredging effects and done with Research and Development/University of California, Los Angeles (RAND/UCLA) Appropriateness Method Scale.

Experts will be asked to rate the importance of each item for ECPR for OHCA using the Grading of Recommendations Assessment, Development and evaluation scale from 1 (strongly disagree) to 9 (strongly agree). Statements will be classified as strong agreement (median score 7-9), neither agree or disagree (median score 4-6), or strongly disagree (median score 1-3). Panel members will also provided an "Unable to Score" response to use if they did not feel comfortable rating any specific domain. Recipients will be asked to recommend any wording/phrasing changes and to suggest any additional items for inclusion.

Based on a previously established Delphi method approach, consensus will be achieved when an item reached a high level of agreement for inclusion. High level of agreement will require greater than 70% of the survey responses for a particular item meeting a score of strong agreement (i.e. a score ≥ 7 on the Likert scale). A medium level of agreement will be defined between 60% and 70%, and low agreement below 60%. Each expert will receive anonymized aggregate statistics (group mean, group standard deviation, percentage agreement). Statements achieving a high level of agreement in the first survey (i.e. a score of 70% of respondents with a score >7) will not be reviewed in the consensus meeting nor in the second survey. Those not meeting a high level of agreement will be rephased during the online meeting or subsequent surveys. If 70% of respondents score a statement at 3 (on the 9-point scale) or less for a statement in the first-round survey, that statement will be deemed not important and removed and not discussed at the online discussion.

An online consensus meeting will be arranged after the first round where the expert panel will discuss the items in detail, including comments on the first survey. Modifications to questions will be possible at this meeting.

Following the online consensus meeting, additional survey rounds will be prepared and sent to each expert as determined by the study group. This survey will include each item with comments indicating changes made during the consensus meeting as well as the mean score and level of agreement (low, medium, high) for each item from the first survey (excluding statements of low importance/agreement as defined above). Expert participants will again rate each item on the same 9-point Likert scale. Descriptive statistics including median, IQR, and level of agreement will be obtained for each item from the final survey. Items that reach a high level of agreement will be included in the final list of consensuses. Items that reached medium or low agreement will be discarded after the final round but will be provided as supplementary data for review.

It is anticipated that 3 rounds of the Delphi process will be required. Additional rounds may be considered if the study group and expert group view additional consensus may be made on key items with restructuring of statements.

The percentage agreement will be quantified as the number of individual scores of more than 7 divided by the number of voting experts. Given the poor- and low-quality data available on many aspects of topic, the study team will not be using the Grading of Recommendation Assessment Development and Evaluation (GRADE) to prepare statements but will referrer to the Appraisal of Guidelines for Research and evaluation (AGREE) statement. This approach is consistent with other recently published guidelines.

03

Conditions studied

  • Cardiac Arrest

Browse trials for

Keywords

  • Extracorporeal membrane oxygenation (ECMO)
  • Extracorporeal membrane oxygenation cardiopulmonary resuscitation (ECPR)
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Internationally recognised experts in extracorporeal membrane oxygenation cardiopulmonary resuscitation (ECPR) and Out of Hospital Cardiac Arrest (OHCA).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Identified experts on ECPR for OHCA based on contributions to the field, clinical experiences, range of specialties and peer-reviewed publications with prioritization of diversity in geography and expertise. Using snowball sampling, we asked the recruited experts to identify additional content experts to participate in the expert panel. We will aim to recruit a total of 50 experts, in accordance with the recommended panel number of >30 as outlined in the original Delphi method paper.

Exclusion criteria

Exclusion Study team members.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Delphi Panel

    The Delphi panel will include between 20-50 international experts in critical care, cardiology, intensive care, anaesthesia, emergency medicine, perfusion and cardio-thoracic surgery.

    Other: Delphi Questionnaire

Interventions

  • OtherDelphi Questionnaire

    Experts will be asked to rate the importance of each item for ECPR for OHCA using the Grading of Recommendations Assessment, Development and evaluation scale from 1 (strongly disagree) to 9 (strongly agree). Statements will be classified as strong agreement (median score 7-9), neither agree or disagree (median score 4-6), or strongly disagree (median score 1-3). Panel members were also provided an "Unable to Score" response to use if they did not feel comfortable rating any specific domain. Recipients will be asked to recommend any wording/phrasing changes and to suggest any additional items for inclusion.

06

What researchers measure

Primary outcomes

  1. Degree of consensus

    The level of agreement for all statements achieving consensus from the expert panel; consensus is predefined as ≥ 70% of the panel rating a given statement \>7 on a likert scale between 1-9

    Time frame: Six months

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Sep 2025, 11 months after the start.

Of 169 non-industry observational studies under Heart Arrest, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 96. This study's planned 11 months is below that.

Counting every sponsor, half of 176 studies reached it within 41 months; a quarter within 18 and three quarters within 90.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 10, 2024
First posted
Aug 14, 2024
StartActual
Oct 30, 2024
Primary completionEst.
Sep 30, 2025
CompletionEst.
Oct 30, 2025
Last update
May 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06552312
Lead sponsor
Sydney Local Health District
Responsible party
Sponsor
First posted
Aug 14, 2024
Start date
Oct 30, 2024
Primary completion
Sep 30, 2025 (estimated)
Completion
Oct 30, 2025 (estimated)
Last update
May 18, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion